VaporTheGamer reacts to skeleton tricky phase 5 and minecraft steve in friday night funkin'! (friday night mining/tricky 5) with fun commentary, unique insights, and FNAF or FNF fan excitement. Alina ...

Intensity Therapeutics (INTS), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase 1/2 results on its candidate for metastatic or refractory cancers, INT230-6. The asset ...

You don't have to be scared of the storm in Escape From Duckov if you are prepared properly. Here you will learn what gear can protect you against those dangerous weather conditions. How to survive ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The allogenic cell therapy achieved all primary and ...

In a recent trial, 11 of 12 children treated with DB-OTO demonstrated meaningful hearing gains. New data from the Phase 1/2 CHORD trial published in The New England Journal of Medicine and presented ...

The MarketWatch News Department was not involved in the creation of this content. This press release contains "forward-looking" statements within the meaning of the "safe harbor" provisions of the ...

Jay Chhablani, MD, presented the phase 1/2 clinical trial data for OCU410, at the 2025 annual meeting of the American Society of Retina Specialists. Jay Chhablani, MD, Vice Chair at the University of ...

Excited to know which Marvel heroes may not be recast after Avengers: Secret Wars? For those unaware, Kevin Feige, president of Marvel Studios, announced that Secret Wars will mark the new beginning ...

EMERALD-1 trial evaluates KB801, a gene therapy for neurotrophic keratitis, focusing on safety and efficacy in corneal healing. KB801 aims to sustain NGF expression in the eye, potentially reducing ...

Krystal Biotech, Inc. announced the dosing of the first patient in its Phase 1/2 clinical trial, EMERALD-1, which is evaluating KB801, an eye drop gene therapy for neurotrophic keratitis (NK), a rare ...